cetpinhibition.org

Torcetrapib

Noninvasive high-definition oscillometry matches implanted telemetry for tracking torcetrapib-induced blood pressure rises in dogs (J Am Assoc Lab Anim Sci 2010)

Original title: Comparison of telemetry and high-definition oscillometry for blood pressure measurements in conscious dogs: effects of torcetrapib

J Am Assoc Lab Anim Sci · · 5

Meyer O, Jenni R, Greiter-Wilke A, Breidenbach A, Holzgrefe HH

Researchers compared torcetrapib-induced blood pressure changes measured simultaneously by high-definition oscillometry (HDO) and telemetry in 6 male beagles given single oral doses of vehicle or torcetrapib at 10 or 30 mg per kg. Both methods showed high precision, though HDO exhibited higher variability across all parameters (mean arterial pressure standard deviation 7.0 plus or minus 2.7 mmHg for HDO versus 3.4 plus or minus 1.9 mmHg for telemetry) and a positive bias (systolic +10.4 mmHg, diastolic +5.7 mmHg, mean arterial pressure +1.9 mmHg). Both methods detected similar maximal mean arterial pressure increases with 30 mg per kg torcetrapib (HDO 15.8 plus or minus 10.4 mmHg, telemetry 15.8 plus or minus 5.3 mmHg), with no significant heart rate effects. Torcetrapib produced dose-dependent blood pressure increases in dogs with lower baseline pressure, but this dose-dependence and the accuracy of HDO readings were both influenced by individual animal temperament.

PubMed

Original abstract

This study compared torcetrapib-induced blood pressure (BP) changes simultaneously obtained by high-definition oscillometry (HDO) and telemetry. Male beagles (n = 6) received single oral doses of vehicle or torcetrapib at 10 or 30 mg/kg; BP were acquired simultaneously by HDO and telemetry from 2 h before dosage until 7 h afterward. Systolic, diastolic, and mean arterial pressures (MAP) and heart rate were compared by using Altman-Bland agreement analysis. Dogs were allocated into subgroups according to temperament and baseline MAP (less than 110 mm Hg and 110 mm Hg or greater). Both methods demonstrated high precision. HDO recordings exhibited higher variability for all parameters (inclusive MAP SDs were 7.0 +/- 2.7 mm Hg for HDO compared with 3.4 +/- 1.9 mm Hg for telemetry), accompanied by a positive bias for all pressures (systolic, 10.4 mm Hg; diastolic, 5.7 mm Hg; MAP, 1.9 mm Hg). Both methods detected similar maximal increases in MAP with 30 mg/kg torcetrapib (HDO, 15.8 +/- 10.4 mm Hg; telemetry, 15.8 +/- 5.3 mm Hg). No significant effects were noted for heart rate. Torcetrapib elicited a dose-dependent increase in BP in dogs with baseline MAP of less than 110 mm Hg, whereas increases were maximal with 10 mg/kg in the other group, and dose-dependence was no longer observed. BP changes were influenced by animal temperament, demonstrating that HDO results must be interpreted with caution. HDO may provide a useful and accurate method for noninvasive BP measurements in canine studies.

blood pressuresafetytorcetrapib

Summary written by cetpinhibition.org from the published abstract; figures as published. Page updated 18 August 2026. Methods.